NextCure Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017
Net Income	-62.72	-74.73	-69.39	-36.6	-33.74	-22.8	-15.47
Depreciation & Amortization	4.26	4.48	4.18	3.41	2.69	1.68	0.58
Share-Based Compensation	8.19	9.51	10.29	7.91	1.89	0.26	0.08
Other Operating Activities	-2.7	6.86	-2.36	-19.68	-6.46	28.85	2.3
Operating Cash Flow	-52.97	-53.89	-57.28	-44.95	-35.62	7.99	-12.51
Capital Expenditures	-0.82	-2.12	-2.36	-7.13	-3.37	-3.06	-8.65
Change in Investments	40.09	70.1	38.96	50.66	-300.55	0	0
Investing Cash Flow	39.27	67.98	36.6	43.52	-303.92	-3.06	-8.65
Share Issuance / Repurchase	0.15	0.2	0.21	0.11	238.5	0	0
Debt Issued / Paid	0	0	-3.47	-1.53	4.54	-0.4	-0.14
Other Financing Activities	-	-	-	-	-	121.81	25
Financing Cash Flow	0.15	0.2	-3.27	-1.42	243.04	121.42	24.86
Net Cash Flow	-13.55	14.29	-23.95	-2.85	-96.5	126.35	3.69
Free Cash Flow	-53.79	-56	-59.64	-52.09	-38.99	4.93	-21.17
Free Cash Flow Margin	-	-	-	-232.76%	-614.37%	-	-
Free Cash Flow Per Share	-1.93	-2.02	-2.16	-1.89	-2.48	3.60	-15.46

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).